News | SANUSq Health

Health on Your Terms

Mental health challenges and recovery strategies in a post-pandemic world

Mental Health in a Post-Pandemic

By SANUSq Research teamApril 01, 2025

The COVID-19 pandemic saw a sharp increase in the prevalence of mental disorders such as anxiety, depression, insomnia, stress, and sleep disorders among both the healthy and “at-risk” people. This unprecedented situation worsened the symptoms and caused a relapse in people who were already suffering from mental health issues.

Exploring the Therapeutic Potential of Palmitoylethanolamide (PEA) in Neurodegenerative Disorders

By SANUSq Research teamFebruary 28, 2025

Neurodegenerative disorders are a group of debilitating conditions characterized by the progressive degeneration and death of neurons in the brain and spinal cord. These disorders can lead to a wide range of symptoms, including cognitive impairment, motor dysfunction, and sensory disturbances, ultimately affecting an individual's quality of life.

Exploring the Potential of Palmitoylethanolamide (PEA) in Managing Autoimmune Disorders

By SANUSq Research teamJanuary 28, 2025

Palmitoylethanolamide (PEA) is a naturally occurring compound found in various plant and animal sources, including human cells. It is a member of the N-acylethanolamine family, which plays a crucial role in regulating various physiological processes within the body.

Palmitoylethanolamide (PEA): A Promising Solution for Inflammatory Bowel Diseases (IBD)

By SANUSq Research teamDecember 29, 2024

Inflammatory Bowel Diseases (IBD) are chronic, relapsing conditions that affect the gastrointestinal tract. These disorders, which include Crohn's disease and ulcerative colitis, can significantly impact your quality of life. Symptoms range from abdominal pain and diarrhea to fatigue and weight loss, often leading to a diminished ability to carry out daily activities.

Unlocking Relief: How Palmitoylethanolamide (PEA) Revolutionises Chronic Pain Management

By SANUSq Research teamNovember 28, 2024

In the realm of chronic pain management, a groundbreaking compound called Palmitoylethanolamide (PEA) is gaining significant attention for its remarkable potential to alleviate persistent discomfort. PEA, a naturally occurring lipid, has emerged as a promising alternative to traditional pain medications, offering a unique approach to addressing the debilitating effects of chronic pain conditions.

Exploring the Health Benefits of Palmitoylethanolamide (PEA)

By SANUSq Research teamNovember 01, 2024

Palmitoylethanolamide (PEA). This intriguing molecule, derived from fatty acids, has emerged as a promising player in the realm of pain management, inflammation reduction, and overall well-being. As you delve into the world of PEA, you'll uncover a fascinating story of scientific discovery and potential therapeutic applications.

Can you reverse type 2 diabetes?

By SANUSq Research teamApril 02, 2024

Type 2 diabetes is a chronic condition where the body either doesn't produce
enough insulin or the cells don't respond to insulin the way they should (insulin resistance).

Signs that your body needs a detox

By SANUSq Research teamMarch 03, 2024

Do you feel lethargic and often suffer from sluggish digestion? Are you struggling with frequent headaches, joint pain and muscle aches?

The Best Herbal Teas for Healthier Sleep and Calmer Mind

By SANUSq Research teamFebruary 03, 2024

A cup of delicious, aromatic herbal tea can soothe your soul. Herbal teas, a prominent part of many cultures, offer amazing benefits for digestion, stress and sleep.